Safeguard Scientifics First Quarter 2011 Financial Results Recap
This morning, we announced our first quarter 2011 financial results and reported on the exciting progress achieved along three key facets of our strategic game…
Posted by
Safeguard Insights
Safeguard Scientifics Fourth Quarter and Year-End Financial Results Recap, Highlighting Aggregate Partner Company Revenue Growth, Acquisitions and IPOs
This morning, we announced our fourth quarter and year-end 2010 financial results. In 2010, our aggregate partner company revenue was $403 million, up 54 percent…
Posted by
2010 Achievements and 2011 Outlook: Safeguard Scientifics, Capital Markets, Regulatory Compliance and more
Last year around this time, as we headed into 2010 and were making plans for the coming year, we were in the midst of the…
Posted by
Communicating Value and Increasing Transparency
Cash on our balance sheet may be growing with every well-timed exit transaction and positive momentum is driving Safeguard’s stock price upward; however, our IR…
Posted by
Clarient and Avid Radiopharmaceuticals Complete Acquisitions
Earlier this quarter, we announced that partner companies Clarient (Nasdaq: CLRT) and Avid Radiopharmaceuticals had signed definitive agreements to be acquired by GE Healthcare and…
Posted by
Eli Lilly Agrees to Acquire Safeguard Scientifics Partner Company Avid Radiopharmaceuticals
For the second time in as many weeks, I am pleased to announce that a major player in the pharmaceutical industry has recognized the value…
Posted by
Aggregate Partner Company Revenue up 73% in Q3; Guidance Increased to between $360 Million to $385 Million
Earlier today in our third quarter results conference call, we announced that our aggregate partner company revenue increased 73 percent in Q3, and that for…
Posted by
Safeguard Scientifics and Partner Company Avid Radiopharmaceuticals Honored with Life Sciences Awards
Today, we were honored by the Philadelphia Business Journal with the Inaugural Life Sciences Venture Impact Award, which “goes to the venture capital firm from…
Posted by
Bloomberg Businessweek says Avid likely to Beat GE, Bayer to Market
On the eve of the International Conference on Alzheimer’s Disease (ICAD), Bloomberg Businessweek’s Elizabeth Lopatto and Kanoko Matsuyama reported that Avid Radiopharmaceuticals, Inc., a Safeguard…
Posted by
